parkerici Profile Banner
Parker Institute for Cancer Immunotherapy Profile
Parker Institute for Cancer Immunotherapy

@parkerici

Followers
11K
Following
4K
Statuses
4K

Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases.

San Francisco, CA
Joined February 2016
Don't wanna be here? Send us removal request.
@parkerici
Parker Institute for Cancer Immunotherapy
9 days
I-O breakthroughs at @UCLAHealth: Antoni Ribas, MD, PhD, Director of PICI Research Center at @UCLA, and @PuigSaus, PhD, PICI Investigator & 2020 Senior Parker Fellow, are developing novel precision treatments for challenging forms of malignant melanoma.
1
6
30
@parkerici
Parker Institute for Cancer Immunotherapy
12 days
From Bench to Fireside is back! Join "the father of CAR T therapy" @carlhjune, Director of the PICI Center at @Penn, as he explores PICI's impact. From CAR T to future pioneers, don't miss his convo with PICI Chief Scientific Officer @John_E_Connolly.
1
7
32
@parkerici
Parker Institute for Cancer Immunotherapy
29 days
New year, new episodes! PICI's podcast From Bench to Fireside is back later this month! Join our CSO @John_E_Connolly for conversations with i-o pioneers including @carlhjune, @EMittendorfMD, @RZappasodi, Toni Ribas & more. Catch up on episodes you missed:
Tweet media one
0
4
19
@parkerici
Parker Institute for Cancer Immunotherapy
2 months
For 8 years, PICI has united world-class researchers around our mission. In 2024, the PICI Network made groundbreaking discoveries, published key papers, received major awards & advanced life-changing new therapies. Explore The 2024 PICI Impact Report:
0
4
11
@parkerici
Parker Institute for Cancer Immunotherapy
2 months
Key discovery: T cells lacking MED12 show reduced activation-induced cell death, offering new perspectives on cellular persistence and immune system regulation. Full study: (3/3)
0
1
2
@parkerici
Parker Institute for Cancer Immunotherapy
2 months
Why it matters: For ~290K Americans diagnosed yearly, prostate cancer remains difficult to treat w/ immunotherapy. This study reveals cellular targets & potential markers to guide new treatments—& identify patients most likely to benefit. (3/3) Read more:
0
2
5
@parkerici
Parker Institute for Cancer Immunotherapy
3 months
@Penn @JoeFraietta @EJohnWherry @EvanWeberPhD @ScienceAdvances This research fundamentally redefines how we can engineer CAR T cells, opening new therapeutic possibilities for cancers that have long resisted current immunotherapy approaches. (3/3)
1
1
2
@parkerici
Parker Institute for Cancer Immunotherapy
3 months
We are thrilled to share the 2024 class of Representation in SciencE (RISE) Scholars, a group of seven exceptional researchers selected through our Diversity, Equity, Inclusion and Belonging (DEIB) Program. Read our latest blog:
0
6
14
@parkerici
Parker Institute for Cancer Immunotherapy
3 months
PICI CSO John Connolly, PhD, discussed the latest immunotherapy trends at @sitcancer’s Annual Meeting over the weekend, with @bradloncar of @BiotechTVHQ. Check out the full interview to hear more from Dr. @John_E_Connolly at #SITC2024:
0
5
15
@parkerici
Parker Institute for Cancer Immunotherapy
3 months
@UCSF @roybal_lab @Nature Congratulations to the team, including collaborator & Nobel laureate David Baker, PhD, Professor of Biochemistry & Director of @UWproteindesign at @UWMedicine, & Co-Founder of PICI portfolio company @Xaira_Thera! (3/3)
0
1
3
@parkerici
Parker Institute for Cancer Immunotherapy
3 months
@Nature Led by Crystal Mackall, MD, Director of the PICI Center at @StanfordMed (@MackallLab), and PICI Project Member @michelle_monje, MD, PhD, this study exemplifies the impact of strategic collaboration in advancing new therapies. (3/3)
0
0
3